DiaMedica Therapeutics (DMAC) Assets (2017 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Assets of $53.1 million for Q1 2026, up 36.7% year-over-year from $38.8 million in Q1 2025, and down 13.51% quarter-over-quarter from $61.4 million in Q4 2025.
DiaMedica Therapeutics (DMAC) Assets (2017 - 2026) Analysis & Trends
DiaMedica Therapeutics' Assets history runs 10 years deep, the most recent figure standing at $53.1 million for Q1 2026.
- In Q1 2026, Assets rose 36.7% year-over-year to $53.1 million; the TTM figure through Mar 2026 stood at $53.1 million (up 36.7% YoY), while the FY2025 annual figure was $61.4 million, up 32.42% from the prior year.
- Assets for Q1 2026 stood at $53.1 million, down from $61.4 million in the prior quarter.
- The five-year high for Assets was $62.0 million in Q2 2023, with the low at $30.2 million in Q1 2023.
- The 5-year median for Assets is $49.3 million (2024), against an average of $47.3 million.
- The sharpest annual moves came in 2022 and 2025: Assets surged 80.3% in 2022, then slumped 44.59% in 2025.
- DiaMedica Therapeutics' Assets stood at $34.4 million in 2022, then jumped by 57.46% to $54.2 million in 2023, then dropped by 14.43% to $46.3 million in 2024, then surged by 32.42% to $61.4 million in 2025, then declined by 13.51% to $53.1 million in 2026.
- Business Quant data shows DMAC's Assets at $53.1 million in Q1 2026, $61.4 million in Q4 2025, and $57.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - | 45.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.00 Mn |
| Mar 31, 2026 | 53.08 Mn |
| Dec 31, 2025 | 61.37 Mn |
| Sep 30, 2025 | 57.05 Mn |
| Jun 30, 2025 | 31.47 Mn |
| Mar 31, 2025 | 38.83 Mn |
| Dec 31, 2024 | 46.35 Mn |
| Sep 30, 2024 | 52.52 Mn |
| Jun 30, 2024 | 56.79 Mn |
| Mar 31, 2024 | 49.26 Mn |
| Dec 31, 2023 | 54.16 Mn |
| Sep 30, 2023 | 58.14 Mn |
| Jun 30, 2023 | 62.05 Mn |
| Mar 31, 2023 | 30.22 Mn |
| Dec 31, 2022 | 34.40 Mn |
| Sep 30, 2022 | 37.04 Mn |
| Jun 30, 2022 | 39.26 Mn |
| Mar 31, 2022 | 42.21 Mn |
| Dec 31, 2021 | 45.55 Mn |
| Sep 30, 2021 | 48.66 Mn |